Literature DB >> 33604074

Prevalence of autism spectrum disorder symptoms in a paediatric neurology clinic at a tertiary hospital in Uganda.

Anita Arinda1, Noeline Nakasujja1, Raymond Odokonyero1.   

Abstract

BACKGROUND: Children with neurological disorders are more likely to present with autism spectrum disorder (ASD) symptoms and get an ASD diagnosis. Despite the large burden of childhood neurological disorders in Uganda, there is limited information on ASD amongst children with neurological disorders in Uganda. AIM: The aim of this study was to determine the prevalence and factors associated with ASD symptoms amongst children attending the paediatric neurology clinic.
SETTING: The study was conducted at the paediatric neurology clinic of Mulago National Referral Hospital in Uganda.
METHODS: This was a cross-sectional study of 318 children aged 2-9 years. After obtaining consent, a socio-demographic questionnaire and the Social Communication Questionnaire were administered to the caregivers of the children. Additional questions were administered to assess the prenatal, birth and postnatal characteristics of the children. Sample characteristics were described using frequencies and means. Bivariate analysis was carried out using chi-square test and Fisher's exact test. Multiple logistic regression models were used to assess which factors were independently associated with ASD symptoms.
RESULTS: The mean age of the children was 5 years and 58.2% were males. The prevalence of significant ASD symptoms was found to be 45%. Factors negatively associated with significant ASD symptoms were female sex (odds ratio [OR] 0.48 [95% CI 0.24, 0.98]) and ability to speak (OR 0.09 [95% CI 0.04, 0.2]). The history of delayed developmental milestones was positively associated with significant ASD symptoms (OR 3.3 [95% CI 1.59, 6.84]).
CONCLUSION: The prevalence of ASD symptoms is high in children with neurological disorders. Children, especially those with delayed developmental milestones, should routinely be screened for ASD.
© 2021. The Authors.

Entities:  

Keywords:  Uganda; associated factors; autism spectrum disorder; neurological disorders; prevalence

Year:  2021        PMID: 33604074      PMCID: PMC7876953          DOI: 10.4102/sajpsychiatry.v27i0.1548

Source DB:  PubMed          Journal:  S Afr J Psychiatr        ISSN: 1608-9685            Impact factor:   1.550


  46 in total

1.  Behavioural problems and autism in children with hydrocephalus : a population-based study.

Authors:  Barbro Lindquist; Göran Carlsson; Eva-Karin Persson; Paul Uvebrant
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-02-23       Impact factor: 4.785

2.  Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation.

Authors:  Linda S Weaving; John Christodoulou; Sarah L Williamson; Kathie L Friend; Olivia L D McKenzie; Hayley Archer; Julie Evans; Angus Clarke; Gregory J Pelka; Patrick P L Tam; Catherine Watson; Hooshang Lahooti; Carolyn J Ellaway; Bruce Bennetts; Helen Leonard; Jozef Gécz
Journal:  Am J Hum Genet       Date:  2004-10-18       Impact factor: 11.025

3.  Between a ROC and a hard place: decision making and making decisions about using the SCQ.

Authors:  Christina Corsello; Vanessa Hus; Andrew Pickles; Susan Risi; Edwin H Cook; Bennett L Leventhal; Catherine Lord
Journal:  J Child Psychol Psychiatry       Date:  2007-09       Impact factor: 8.982

4.  Validation of the social communication questionnaire in a population cohort of children with autism spectrum disorders.

Authors:  Susie Chandler; Tony Charman; Gillian Baird; Emily Simonoff; Tom Loucas; David Meldrum; Mimi Scott; Andrew Pickles
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-10       Impact factor: 8.829

Review 5.  Sex differences in autism spectrum disorders.

Authors:  Donna M Werling; Daniel H Geschwind
Journal:  Curr Opin Neurol       Date:  2013-04       Impact factor: 5.710

6.  Comparative analysis of three screening instruments for autism spectrum disorder in toddlers at high risk.

Authors:  Iris J Oosterling; Sophie H Swinkels; Rutger Jan van der Gaag; Janne C Visser; Claudine Dietz; Jan K Buitelaar
Journal:  J Autism Dev Disord       Date:  2009-02-10

7.  Prevalence of cerebral palsy in Uganda: a population-based study.

Authors:  Angelina Kakooza-Mwesige; Carin Andrews; Stefan Peterson; Fred Wabwire Mangen; Ann Christin Eliasson; Hans Forssberg
Journal:  Lancet Glob Health       Date:  2017-11-05       Impact factor: 26.763

8.  Rites of passage: understanding participation of children with developmental coordination disorder.

Authors:  A D Mandich; H J Polatajko; S Rodger
Journal:  Hum Mov Sci       Date:  2003-11       Impact factor: 2.161

9.  Psychological problems in children with cerebral palsy: a cross-sectional European study.

Authors:  Jackie Parkes; Melanie White-Koning; Heather O Dickinson; Ute Thyen; Catherine Arnaud; Eva Beckung; Jerome Fauconnier; Marco Marcelli; Vicki McManus; Susan I Michelsen; Kathryn Parkinson; Allan Colver
Journal:  J Child Psychol Psychiatry       Date:  2007-12-12       Impact factor: 8.982

10.  Sensitivity and specificity of early screening for autism.

Authors:  Pål Surén; Alexandra Saasen-Havdahl; Michaeline Bresnahan; Deborah Hirtz; Mady Hornig; Catherine Lord; Ted Reichborn-Kjennerud; Synnve Schjølberg; Anne-Siri Øyen; Per Magnus; Ezra Susser; W Ian Lipkin; Camilla Stoltenberg
Journal:  BJPsych Open       Date:  2019-05-17
View more
  2 in total

1.  Sex differences in age of diagnosis of autism spectrum disorder: Preliminary evidence from Uganda.

Authors:  Emmanuel Bonney; Catherine Abbo; Collin Ogara; Michele E Villalobos; Jed T Elison
Journal:  Autism Res       Date:  2021-11-26       Impact factor: 5.216

2.  Urinary metabolomics using gas chromatography-mass spectrometry: potential biomarkers for autism spectrum disorder.

Authors:  Zaib Un Nisa Khan; Prem Chand; Hafsa Majid; Sibtain Ahmed; Aysha Habib Khan; Azeema Jamil; Saba Ejaz; Ambreen Wasim; Khaleel Ahmad Khan; Lena Jafri
Journal:  BMC Neurol       Date:  2022-03-17       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.